Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up

Mov Disord. 2002 Jan;17(1):188-91. doi: 10.1002/mds.1276.

Abstract

Twelve patients with levodopa-induced dyskinesias were treated with continuous subcutaneous apomorphine. A markedly significant reduction in peak dose dyskinesias occurred over a two-year follow-up.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Apomorphine / administration & dosage
  • Apomorphine / therapeutic use*
  • Dopamine Agonists / administration & dosage
  • Dopamine Agonists / therapeutic use*
  • Drug Administration Schedule
  • Dyskinesia, Drug-Induced / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Subcutaneous
  • Levodopa / adverse effects
  • Levodopa / therapeutic use*
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Prospective Studies
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Levodopa
  • Apomorphine